CathVision, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, has completed a venture round of €13m (US$14.4m). The round was from Vaekstfonden, a…
CathVision, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, has completed a venture round of €13m (US$14.4m). The round was from Vaekstfonden, a…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference